All News

Gene Editing

Manufacture of Healthy and Highly Functioning Gene-Edited Immune Cells
8 March 2023
Manufacture of Healthy and Highly Functioning Gene-Edited Immune Cells
Are you looking to engineer
Gene Editing: Tools and Technology of the Future
11 January 2023
Gene Editing: Tools and Technology of the Future
For this interview, Phacilitate’s Becky
Early Considerations for Commercial Success
4 January 2023
Early Considerations for Commercial Success
For this interview, Phacilitate’s Becky
Genome Editing Tools and Techniques for Cancer Therapies
3 January 2023
Genome Editing Tools and Techniques for Cancer Therapies
For this interview, Phacilitate’s Ryan
POPULAR NEWS ITEMS
Image
23 March 2023

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image
14 March 2023

Pfizer Invests $43 Billion to Acquire Seagen

Image
2 March 2023

Early Adoption and Partnerships – The Secret to Commercialization Success?

Improving Novel Theraputics and Early-Phase Trials
5 December 2022
Improving Novel Theraputics and Early-Phase Trials
For this interview, Phacilitate’s Ryan
Commercial Considerations in the World of Rare Diseases
5 December 2022
Commercial Considerations in the World of Rare Diseases
For this interview, Phacilitate’s Becky
“Endowing Cells with Super-Physical Properties” to Better Treat Patient Populations
29 November 2022
“Endowing Cells with Super-Physical Properties” to Better Treat Patient Populations
For this interview, Phacilitate’s Ryan
The Advanced Therapies Workforce Evolution
29 November 2022
The Advanced Therapies Workforce Evolution
For this interview, Phacilitate’s Becky
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Gilead’s Yescarta Demonstrates Improvement in Overall Survival for Aggressive Blood Cancers

Image

Pfizer Invests $43 Billion to Acquire Seagen

Image

Early Adoption and Partnerships – The Secret to Commercialization Success?